Zurich Cantonal Bank’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,877
| Closed | -$73K | – | 2678 |
|
|
2019
Q3 | $73K | Hold |
3,877
| – | – | ﹤0.01% | 1788 |
|
|
2019
Q2 | $46K | Hold |
3,877
| – | – | ﹤0.01% | 2120 |
|
|
2019
Q1 | $53K | Buy |
3,877
+175
| +5% | +$2.27K | ﹤0.01% | 1967 |
|
|
2018
Q4 | $38K | Hold |
3,702
| – | – | ﹤0.01% | 2190 |
|
|
2018
Q3 | $62K | Buy |
3,702
+636
| +21% | +$11.5K | ﹤0.01% | 2024 |
|
|
2018
Q2 | $48K | Hold |
3,066
| – | – | ﹤0.01% | 2158 |
|
|
2018
Q1 | $39K | Hold |
3,066
| – | – | ﹤0.01% | 2207 |
|
|
2017
Q4 | $35K | Buy |
3,066
+2,038
| +198% | +$22.7K | ﹤0.01% | 2237 |
|
|
2017
Q3 | $13K | Hold |
1,028
| – | – | ﹤0.01% | 2381 |
|
|
2017
Q2 | $12K | Hold |
1,028
| – | – | ﹤0.01% | 2401 |
|
|
2017
Q1 | $21K | Hold |
1,028
| – | – | ﹤0.01% | 2294 |
|
|
2016
Q4 | $21K | Hold |
1,028
| – | – | ﹤0.01% | 2256 |
|
|
2016
Q3 | $34K | Buy |
1,028
+197
| +24% | +$6K | ﹤0.01% | 1908 |
|
|
2016
Q2 | $21K | Hold |
831
| – | – | ﹤0.01% | 2083 |
|
|
2016
Q1 | $20K | Hold |
831
| – | – | ﹤0.01% | 2075 |
|
|
2015
Q4 | $27K | Buy |
831
+583
| +235% | +$19.7K | ﹤0.01% | 1848 |
|
|
2015
Q3 | $8K | Buy |
+248
| New | +$10.5K | ﹤0.01% | 2252 |
|
Zurich Cantonal Bank's ALDR Position: Q4 2019 in Review
Zurich Cantonal Bank sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 3,877 shares — an estimated $73K sold.
Zurich Cantonal Bank first reported a position in ALDR in Q3 2015 and held it in 17 quarters. The position peaked at $73K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Zurich Cantonal Bank reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Zurich Cantonal Bank sold 3,877 Alder Biopharmaceuticals shares in Q4 2019, an estimated $73K.
- Zurich Cantonal Bank first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 17 quarters.
- Zurich Cantonal Bank's Alder Biopharmaceuticals position peaked at $73K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Zurich Cantonal Bank's 13F filing for Q4 2019, filed 21 Jan 2020.